| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |